These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 12868196

  • 21. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T, Møller J, Fisker S, Jorgensen JO, Christiansen JS.
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [Abstract] [Full Text] [Related]

  • 22. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO.
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [Abstract] [Full Text] [Related]

  • 23. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ.
    J Diabetes Complications; 2005 Feb; 19(5):297-304. PubMed ID: 16112506
    [Abstract] [Full Text] [Related]

  • 24. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 Feb; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 25. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z, Haas T.
    Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
    [Abstract] [Full Text] [Related]

  • 26. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
    Amin R, Williams RM, Frystyk J, Umpleby M, Matthews D, Orskov H, Dalton RN, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
    [Abstract] [Full Text] [Related]

  • 27. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 28. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z.
    Cas Lek Cesk; 2001 Apr 26; 140(8):234-7. PubMed ID: 11392040
    [Abstract] [Full Text] [Related]

  • 29. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Apr 26; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 30. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
    Obesity (Silver Spring); 2008 Jul 26; 16(7):1516-21. PubMed ID: 18464752
    [Abstract] [Full Text] [Related]

  • 31. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
    Gunnell D, Miller LL, Rogers I, Holly JM, ALSPAC Study Team.
    Pediatrics; 2005 Nov 26; 116(5):e681-6. PubMed ID: 16263982
    [Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.
    Scand J Clin Lab Invest; 2007 Nov 26; 67(5):553-9. PubMed ID: 17763192
    [Abstract] [Full Text] [Related]

  • 33. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 26; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

  • 34. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents.
    Kong AP, Wong GW, Choi KC, Ho CS, Chan MH, Lam CW, Tong PC, Ozaki R, So WY, Ma RC, Lau JT, Chan JC.
    Clin Biochem; 2007 Oct 26; 40(15):1093-9. PubMed ID: 17673197
    [Abstract] [Full Text] [Related]

  • 35. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.
    Justová V, Lacinová Z, Melenovský V, Marek J, Holly JM, Hass T.
    Growth Horm IGF Res; 2001 Dec 26; 11(6):407-15. PubMed ID: 11914029
    [Abstract] [Full Text] [Related]

  • 36. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V, Román R, Iñiguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F.
    Horm Res; 2007 Dec 26; 68(3):132-8. PubMed ID: 17347571
    [Abstract] [Full Text] [Related]

  • 37. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P.
    J Clin Endocrinol Metab; 1997 Apr 26; 82(4):1181-7. PubMed ID: 9100593
    [Abstract] [Full Text] [Related]

  • 38. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ, Luo SM, Hu WJ.
    Zhonghua Wai Ke Za Zhi; 2005 Jun 01; 43(11):697-701. PubMed ID: 16008955
    [Abstract] [Full Text] [Related]

  • 39. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
    Krsek M, Skrha J, Sucharda P, Justová V, Lacinová Z.
    Cas Lek Cesk; 2003 Jun 01; 142(4):216-9. PubMed ID: 12841123
    [Abstract] [Full Text] [Related]

  • 40. Profound changes in the GH-IGF-I system in adolescent girls with IDDM: can IGFBP1 be used to reflect overall glucose regulation?
    Halldin MU, Hagenäs L, Tuvemo T, Gustafsson J.
    Pediatr Diabetes; 2000 Sep 01; 1(3):121-30. PubMed ID: 15016222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.